Royal Bank of Canada’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-462
| Closed | -$9K | – | 7101 |
|
|
2023
Q3 | $9K | Sell |
462
-13,545
| -97% | -$301K | ﹤0.01% | 6441 |
|
|
2023
Q2 | $336K | Sell |
14,007
-4,589
| -25% | -$111K | ﹤0.01% | 4269 |
|
|
2023
Q1 | $408K | Sell |
18,596
-22,501
| -55% | -$566K | ﹤0.01% | 4038 |
|
|
2022
Q4 | $1.03M | Sell |
41,097
-2,727
| -6% | -$67.8K | ﹤0.01% | 3482 |
|
|
2022
Q3 | $1.08M | Sell |
43,824
-34,566
| -44% | -$881K | ﹤0.01% | 3393 |
|
|
2022
Q2 | $1.69M | Sell |
78,390
-6,908
| -8% | -$152K | ﹤0.01% | 3036 |
|
|
2022
Q1 | $2.38M | Sell |
85,298
-9,433
| -10% | -$279K | ﹤0.01% | 2901 |
|
|
2021
Q4 | $3.65M | Sell |
94,731
-15,645
| -14% | -$667K | ﹤0.01% | 2619 |
|
|
2021
Q3 | $5.04M | Buy |
110,376
+5,334
| +5% | +$249K | ﹤0.01% | 2280 |
|
|
2021
Q2 | $5.25M | Buy |
105,042
+15,629
| +17% | +$765K | ﹤0.01% | 2285 |
|
|
2021
Q1 | $4.59M | Sell |
89,413
-5,706
| -6% | -$312K | ﹤0.01% | 2300 |
|
|
2020
Q4 | $4.72M | Buy |
95,119
+3,401
| +4% | +$153K | ﹤0.01% | 2223 |
|
|
2020
Q3 | $3.58M | Sell |
91,718
-832
| -0.9% | -$33.9K | ﹤0.01% | 2228 |
|
|
2020
Q2 | $4M | Sell |
92,550
-56,251
| -38% | -$2.15M | ﹤0.01% | 2107 |
|
|
2020
Q1 | $4.36M | Buy |
148,801
+31,870
| +27% | +$1.1M | ﹤0.01% | 1904 |
|
|
2019
Q4 | $4.45M | Sell |
116,931
-31,495
| -21% | -$937K | ﹤0.01% | 2240 |
|
|
2019
Q3 | $3.54M | Buy |
148,426
+31,709
| +27% | +$862K | ﹤0.01% | 2322 |
|
|
2019
Q2 | $3.36M | Buy |
116,717
+18,757
| +19% | +$524K | ﹤0.01% | 2364 |
|
|
2019
Q1 | $2.79M | Buy |
97,960
+20,798
| +27% | +$545K | ﹤0.01% | 2444 |
|
|
2018
Q4 | $1.79M | Buy |
77,162
+18,406
| +31% | +$502K | ﹤0.01% | 2738 |
|
|
2018
Q3 | $2.03M | Buy |
58,756
+4,200
| +8% | +$142K | ﹤0.01% | 2838 |
|
|
2018
Q2 | $1.78M | Buy |
54,556
+1,938
| +4% | +$63.7K | ﹤0.01% | 2819 |
|
|
2018
Q1 | $1.73M | Buy |
52,618
+7,678
| +17% | +$251K | ﹤0.01% | 2788 |
|
|
2017
Q4 | $1.28M | Buy |
44,940
+17,037
| +61% | +$477K | ﹤0.01% | 3068 |
|
|
2017
Q3 | $813K | Buy |
27,903
+2,079
| +8% | +$53.8K | ﹤0.01% | 3398 |
|
|
2017
Q2 | $620K | Buy |
25,824
+3,969
| +18% | +$88.9K | ﹤0.01% | 3499 |
|
|
2017
Q1 | $507K | Sell |
21,855
-15,728
| -42% | -$334K | ﹤0.01% | 3626 |
|
|
2016
Q4 | $692K | Buy |
37,583
+23,534
| +168% | +$469K | ﹤0.01% | 3468 |
|
|
2016
Q3 | $318K | Buy |
14,049
+3,493
| +33% | +$71.6K | ﹤0.01% | 4087 |
|
|
2016
Q2 | $190K | Buy |
10,556
+8,601
| +440% | +$169K | ﹤0.01% | 4440 |
|
|
2016
Q1 | $37K | Buy |
1,955
+1,080
| +123% | +$20.9K | ﹤0.01% | 5251 |
|
|
2015
Q4 | $25K | Buy |
875
+184
| +27% | +$5.32K | ﹤0.01% | 5613 |
|
|
2015
Q3 | $18K | Buy |
+691
| New | +$23.4K | ﹤0.01% | 5603 |
|
Other funds holding BBC
FDCDDQ
DI
DWS
DSC